{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:56:15Z","timestamp":1790776575119,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T00:00:00Z","timestamp":1315440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-389","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T06:18:00Z","timestamp":1315462680000},"source":"Crossref","is-referenced-by-count":63,"title":["Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study"],"prefix":"10.1186","volume":"11","author":[{"given":"Melissa J","family":"Newton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandi C","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope M","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa G","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,8]]},"reference":[{"key":"2895_CR1","volume-title":"Cancer in Australia 2000","author":"Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR)","year":"2003","unstructured":"Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR): Cancer in Australia 2000. 2003, Canberra: AIHW (Cancer Series no 23), AIHW Cat. No. CAN 18"},{"key":"2895_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung H: Chemotherapy-induced peripheral neuropathy. J Neurol. 2002, 249: 9-17. 10.1007\/PL00007853.","journal-title":"J Neurol"},{"key":"2895_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/IGC.0b013e3181dbd13f","volume":"20","author":"LG Gordon","year":"2010","unstructured":"Gordon LG, Scuffham PA, Beesley VL, Green AC, DeFazio A, Wyld DK, Clavarino AM, Australian Ovarian Cancer Study Group, Webb PM: Outcomes and related medical costs for women with ovarian cancer in Australia: a patient-level analysis over 21\/2 years. Int J Gynecol Cancer. 2010, 20: 757-765. 10.1111\/IGC.0b013e3181dbd13f.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2895_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1081\/CNV-120027582","volume":"22","author":"A Schwartz","year":"2004","unstructured":"Schwartz A: Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest. 2004, 22 (1): 82-92. 10.1081\/CNV-120027582.","journal-title":"Cancer Invest"},{"issue":"11","key":"2895_CR5","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1158\/1055-9965.EPI-07-0566","volume":"16","author":"CM Olsen","year":"2007","unstructured":"Olsen CM, Bain CJ, Jordan S, Nagle C, Green A, Whiteman D, Webb P, Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group: Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systematic Review, and Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2007, 16 (11): 2321-2330. 10.1158\/1055-9965.EPI-07-0566.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2895_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/gyno.2000.5908","volume":"78","author":"D Bodurka-Bevers","year":"2000","unstructured":"Bodurka-Bevers D, Basen-Engquist K, Carmack C, Fitzgerald M, Wolf J, de Moor C, Gershenson D: Depression, Anxiety, and Quality of Life in Patients with Epithelial Ovarian Cancer. Gynecol Oncol. 2000, 78: 302-308. 10.1006\/gyno.2000.5908.","journal-title":"Gynecol Oncol"},{"key":"2895_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1200\/JCO.2006.07.3494","volume":"25","author":"L Wenzel","year":"2007","unstructured":"Wenzel L, Huang H, Armstrong D, Walker J, Cella D: Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007, 25: 437-443. 10.1200\/JCO.2006.07.3494.","journal-title":"J Clin Oncol"},{"key":"2895_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis T, McFadden ET, Carbone P: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5: 649-655. 10.1097\/00000421-198212000-00014.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2895_CR9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"M Markman","year":"2001","unstructured":"Markman M, Bundy B, Alberts D, Clark-Pearson DL, Carson LF, Wadler S, Sickel J: Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol. 2001, 19 (4): 1001-1007.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2895_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang H, Baergen R, Lele S, Copeland L, Walker J, Burger R, for the Gynecologic Oncology Group: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New Eng J Med. 2006, 354 (1): 34-43. 10.1056\/NEJMoa052985.","journal-title":"New Eng J Med"},{"key":"2895_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1040-8428(02)00133-6","volume":"46","author":"A Hirria","year":"2003","unstructured":"Hirria A, Leung D, Trainor K, Borgen P, Norton L, Hudis C: Factor influencing treatment patterns of breast cancer patients age 75 and older. Crit Rev Oncol Hematol. 2003, 46: 121-126. 10.1016\/S1040-8428(02)00133-6.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2895_CR12","first-page":"97","volume":"5","author":"CC Law","year":"2002","unstructured":"Law CC, Fu YT: Postoperative adjuvant 5-Fluororuacil plus levamisole chemotherapy for stage III colon carcinoma: 7-year experience in a single institution. J Hong Kong College Rad. 2002, 5: 97-104.","journal-title":"J Hong Kong College Rad"},{"key":"2895_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00001813-200404000-00005","volume":"15","author":"R D'hondt","year":"2004","unstructured":"D'hondt R, Paridaens R, Wildiers H, Pauwelyn K, Thomas J, Dumez H, Van Oosterom A: Safety and efficacy of weekly docetaxel in frail and\/or elderly patients with metastatic breast cancer: a phase II study. Anticancer Drug. 2004, 15: 341-346. 10.1097\/00001813-200404000-00005.","journal-title":"Anticancer Drug"},{"key":"2895_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11764-009-0110-5","volume":"4","author":"RM Speck","year":"2010","unstructured":"Speck RM, Courneya KS, M\u00e2sse LC, Duval S, Schmitz KH: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010, 4: 87-100. 10.1007\/s11764-009-0110-5.","journal-title":"J Cancer Surviv"},{"key":"2895_CR15","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","volume":"25","author":"KS Courneya","year":"2007","unstructured":"Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid R, Friedenreich C, Ladha A, Proulx C, Vallance J, Lane K, Yasui Y, McKenzie D: Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007, 25: 4396-4404. 10.1200\/JCO.2006.08.2024.","journal-title":"J Clin Oncol"},{"key":"2895_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jsams.2009.03.002","volume":"12","author":"SC Hayes","year":"2009","unstructured":"Hayes SC, Spence RR, Galvao DA, Newton R: Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise. J Sci Med Sport. 2009, 12: 428-434. 10.1016\/j.jsams.2009.03.002.","journal-title":"J Sci Med Sport"},{"key":"2895_CR17","volume-title":"Gynecol Oncol","author":"V Von Gruenigen","year":"2011","unstructured":"Von Gruenigen V, Frasure H, Kavanagh M, Lerner E, Waggoner SE, Courneya KS: Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011,"},{"key":"2895_CR18","doi-asserted-by":"crossref","unstructured":"ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166: 111-117.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"issue":"6","key":"2895_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67 (6): 361-370. 10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"key":"2895_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y","volume":"89","author":"V Chang","year":"2000","unstructured":"Chang V, Hwang S, Feuerman M, Kasimis B, Thaler H: The Memorial Symptom Assessment Scale Short Form (MSAS-SF) Validity and Reliability. Cancer. 2000, 89: 1162-1171. 10.1002\/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y.","journal-title":"Cancer"},{"key":"2895_CR21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","volume":"19","author":"K Basen-Engquist","year":"2001","unstructured":"Basen-Engquist K, Bodurka-Bevers D, Fitzgerald M, Webster K, Cella D, Hu S, Gershenson D: Reliability and validity of the functional assessment of cancer therapy - Ovarian. J Clin Oncol. 2001, 19: 1809-1817.","journal-title":"J Clin Oncol"},{"key":"2895_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1756-9966-28-116","volume":"28","author":"Y Terada","year":"2009","unstructured":"Terada Y, Nakamae H, Aimoto R, Kanashima H, Sakamoto E, Aimoto M, Inoue E, Koh H, Nakane T, Takeoka Y, Ohsawa M, Koh KR, Yamane T, Nakao Y, Ohta K, Mugitani A, Teshima H, Hino M: Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma. J Exper Clin Can Res. 2009, 28: 116-10.1186\/1756-9966-28-116.","journal-title":"J Exper Clin Can Res"},{"issue":"8","key":"2895_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1445-5994.2008.01880.x","volume":"39","author":"T Rasekaba","year":"2009","unstructured":"Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE: The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009, 39 (8): 495-501. 10.1111\/j.1445-5994.2008.01880.x.","journal-title":"Intern Med J"},{"key":"2895_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-6-46","volume":"6","author":"M Puhan","year":"2008","unstructured":"Puhan M, Frey M, B\u00fcchi S, Sch\u00fcnemann H: The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcome. 2008, 6: 46-10.1186\/1477-7525-6-46.","journal-title":"Health Qual Life Outcome"},{"issue":"No 15S","key":"2895_CR25","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1200\/jco.2008.26.15_suppl.20689","volume":"26","author":"P Walker","year":"2008","unstructured":"Walker P: Which symptoms are prevalent in patients with recurrent ovarian cancer?. J Clin Oncol. 2008, 26 (No 15S): 20689-","journal-title":"J Clin Oncol"},{"issue":"12","key":"2895_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jclinepi.2005.07.009","volume":"58","author":"JA Sloan","year":"2005","unstructured":"Sloan JA, Cella D, Hays RD: Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol. 2005, 58 (12): 1217-1219. 10.1016\/j.jclinepi.2005.07.009.","journal-title":"J Clin Epidemiol"},{"key":"2895_CR27","unstructured":"Queensland Centre for Gynecological Cancer. Outcome data statistical report. 2008"},{"key":"2895_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/pon.658","volume":"12","author":"KS Courneya","year":"2003","unstructured":"Courneya KS, Friedenreich CM, Sela RA, Quinney HA, Rhodes RE, Handman M: The group psychotherapy and home-based physical exercise (Group-Hope) trail in cancer survivors: Physical fitness and quality of life outcomes. Psycho-oncology. 2003, 12: 357-374. 10.1002\/pon.658.","journal-title":"Psycho-oncology"},{"issue":"4","key":"2895_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/pon.1396","volume":"18","author":"C Stevinson","year":"2009","unstructured":"Stevinson C, Capstick V, Schepansky A, Tonkin K, Vallance JK, Ladha AB, Steed H, Faught W, Courneya KS: Physical activity preferences of ovarian cancer survivors. Psycho-oncology. 2009, 18 (4): 422-428. 10.1002\/pon.1396.","journal-title":"Psycho-oncology"},{"key":"2895_CR30","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdm121","volume":"18","author":"F Joly","year":"2007","unstructured":"Joly F, Vardy J, Pintilie M, Tannock I: Quality of life and\/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol. 2007, 18: 1935-1942. 10.1093\/annonc\/mdm121.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-389\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T05:57:26Z","timestamp":1497938246000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2895"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-389","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,8]]},"article-number":"389"}}